本周,SEC 文件中披露了这一决定,这对 Pieris 来说又是一个打击,去年,在与阿斯利康的单独合作终止后,该公司已经进行了重大重组。
Pieris(PIRS)05-18 05:15
$Pieris(PIRS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-001270 Act: 34 Size: 294 KB 网页链接查看全文
Pieris(PIRS)05-16 04:05
$Pieris(PIRS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-017037 Act: 34 Size: 5 MB 网页链接查看全文
Pieris(PIRS)05-18 05:15
$Pieris(PIRS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-001271 Act: 34 Size: 294 KB 网页链接查看全文
Pieris(PIRS)04-30 05:05
$Pieris(PIRS)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-24-013736 Act: 34 Size: 805 KB 网页链接查看全文
Pieris(PIRS)07-04 04:35
$Pieris(PIRS)$ 8-K Current report, items 1.02, 8.01, and 9.01 Accession Number: 0001437749-24-022188 Act: 34 Size: 171 KB 网页链接查看全文
Pieris(PIRS)07-24 18:45
$Pieris(PIRS)$ 425 Prospectuses and communications, business combinations Accession Number: 0001437749-24-023302 Act: 34 Size: 6 MB 网页链接查看全文
Pieris(PIRS)07-24 18:45
$Pieris(PIRS)$ 8-K Current report, items 1.01, 3.02, 5.02, 8.01, and 9.01 Accession Number: 0001437749-24-023301 Act: 34 Size: 7 MB 网页链接查看全文
凤凰网港股|Pieris制药公司(PIRS)宣布开发PRS-220,一种针对结缔组织生长因子(CTGF)(CCN2的口服吸入性抗癌蛋白),用于治疗特发性肺纤维化(IPF)。 该公司还宣布它已被选中获得巴伐利亚州经济事务、地区发展和能源部提供的1700万美元的资助,... 网页链接
格隆汇5月26日丨生物制药公司Pieris Pharmaceuticals(PIRS.US)高开低走,盘中一度大涨35%至5.09美元,现涨4.79%报3.94美元,暂成交3.21亿美元,最新市值2.49亿美元,换手率高达172.7%。 公司此前宣布与基因泰克公司在呼吸和眼科方面的合作。 网页链接
$Pieris(PIRS)$ 8-K Current report, items 1.01, 3.02, 5.02, 8.01, and 9.01 Accession Number: 0001437749-24-023301 Act: 34 Size: 7 MB 网页链接
$Pieris(PIRS)$ 425 Prospectuses and communications, business combinations Accession Number: 0001437749-24-023302 Act: 34 Size: 6 MB 网页链接
$Pieris(PIRS)$ 8-K Current report, items 1.02, 8.01, and 9.01 Accession Number: 0001437749-24-022188 Act: 34 Size: 171 KB 网页链接
$Pieris(PIRS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-001271 Act: 34 Size: 294 KB 网页链接
$Pieris(PIRS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-001270 Act: 34 Size: 294 KB 网页链接
$Pieris(PIRS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-017037 Act: 34 Size: 5 MB 网页链接
$Pieris(PIRS)$ 8-K Current report, item 8.01 Accession Number: 0001437749-24-015466 Act: 34 Size: 160 KB 网页链接
$Pieris(PIRS)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-24-013736 Act: 34 Size: 805 KB 网页链接
$Pieris(PIRS)$ 8-K Current report, items 3.03, 5.03, 7.01, and 9.01 Accession Number: 0001437749-24-012442 Act: 34 Size: 681 KB 网页链接
$Pieris(PIRS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-24-010123 Act: 34 Size: 8 MB 网页链接